Sumitomo Mitsui Trust Holdings, Inc. Global Blood Therapeutics, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 25, 2021	SELL	$25.48 - $37.34 $183,914 - $269,520	-7,218 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$32.46 - $43.42 $15,093 - $20,190	-465 Reduced 6.05%	7,218 $253,000
Q1 2021 Apr 30, 2021	SELL	$38.94 - $50.85 $8,839 - $11,542	-227 Reduced 2.87%	7,683 $313,000
Q4 2020 Feb 05, 2021	BUY	$37.65 - $63.77 $22,025 - $37,305	585 Added 7.99%	7,910 $343,000
Q2 2020 Jul 27, 2020	SELL	$48.73 - $81.82 $23,731 - $39,846	-487 Reduced 6.23%	7,325 $462,000
Q1 2020 Apr 27, 2020	BUY	$41.72 - $87.2 $325,916 - $681,206	7,812 New	7,812 $399,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.